Departments of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, United States.
Departments of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, United States.
Oral Oncol. 2017 Aug;71:122-128. doi: 10.1016/j.oraloncology.2017.05.009. Epub 2017 Jun 23.
To characterize the recognized but poorly understood long-term toxicities of radiation therapy (RT) for head and neck cancer (HNC).
We retrospectively evaluated patients treated with curative-intent RT for HNC between 1990 and 2005 at a single institution with systematic multidisciplinary follow-up ≥10years. Long-term toxicities of the upper aerodigestive tract were recorded and assigned to two broad categories: pharyngeal-laryngeal and oral cavity toxicity. Kaplan-Meier estimates and Chi-square tests were used for univariable analysis (UVA). Cox model and logistic regression were used for multivariable analysis (MVA).
We identified 112 patients with follow-up ≥10years (median 12.2). The primary tumor sites were pharynx (42%), oral cavity (34%), larynx (13%), and other (11%). Forty-four percent received postoperative RT, 24% had post-RT neck dissection, and 47% received chemotherapy. Twenty-eight (25%) patients developed pharyngeal-laryngeal toxicity, including 23 (21%) requiring permanent G-tube placed at median of 5.6years (0-20.3) post-RT. Fifty-three (47%) developed oral cavity toxicity, including osteoradionecrosis in 25 (22%) at a median of 7.2years (0.5-15.3) post-RT. On MVA, pharyngeal-laryngeal toxicity was significantly associated with chemotherapy (HR 3.24, CI 1.10-9.49) and age (HR 1.04, CI 1.00-1.08); oral cavity toxicity was significantly associated with chemotherapy (OR 4.40, CI 1.51-12.9), oral cavity primary (OR 5.03, CI 1.57-16.1), and age (OR 0.96, CI 0.92-1.00).
Among irradiated HNC patients, pharyngeal-laryngeal and oral cavity toxicity commonly occur years after radiation, especially in those treated with chemotherapy. Follow-up for more than five years is essential because these significant problems afflict patients who have been cured.
描述头颈部癌症(HNC)放射治疗(RT)的已知但了解甚少的长期毒性。
我们在一家机构回顾性评估了 1990 年至 2005 年间接受根治性 RT 治疗的 HNC 患者,这些患者接受了系统的多学科随访,随访时间≥10 年。记录上呼吸道的长期毒性,并将其分为两个广泛的类别:咽-喉毒性和口腔毒性。Kaplan-Meier 估计和卡方检验用于单变量分析(UVA)。Cox 模型和逻辑回归用于多变量分析(MVA)。
我们确定了 112 例随访时间≥10 年(中位数 12.2 年)的患者。原发肿瘤部位为咽(42%)、口腔(34%)、喉(13%)和其他(11%)。44%的患者接受了术后 RT,24%的患者在 RT 后接受了颈部清扫术,47%的患者接受了化疗。28 例(25%)患者出现咽-喉毒性,其中 23 例(21%)需要永久性 G 管,中位数时间为 RT 后 5.6 年(0-20.3 年)。53 例(47%)患者发生口腔毒性,包括 25 例(22%)放射性骨坏死,中位数时间为 RT 后 7.2 年(0.5-15.3 年)。在 MVA 中,咽-喉毒性与化疗显著相关(HR 3.24,CI 1.10-9.49)和年龄(HR 1.04,CI 1.00-1.08);口腔毒性与化疗显著相关(OR 4.40,CI 1.51-12.9)、口腔原发(OR 5.03,CI 1.57-16.1)和年龄(OR 0.96,CI 0.92-1.00)。
在接受放疗的 HNC 患者中,咽-喉和口腔毒性通常在放疗后数年发生,尤其是在接受化疗的患者中。随访时间超过五年是必要的,因为这些严重的问题困扰着已经治愈的患者。